Search

Your search keyword '"Casper M"' showing total 687 results

Search Constraints

Start Over You searched for: Author "Casper M" Remove constraint Author: "Casper M"
687 results on '"Casper M"'

Search Results

451. MUTYH gene expression and alternative splicing in controls and polyposis patients.

452. MUTYH hotspot mutations in unselected colonoscopy patients.

453. [Gallstone disease: basic mechanisms, diagnosis and therapy].

454. Racial residential segregation and stroke mortality in Atlanta.

455. Cancer risk in chronic hepatitis B: Do genome-wide association studies hit the mark?

456. Adenoma development in a patient with MUTYH-associated polyposis (MAP): new insights into the natural course of polyp development.

457. Overreporting of deaths from coronary heart disease in New York City hospitals, 2003.

458. Geographic disparities in heart failure hospitalization rates among Medicare beneficiaries.

459. Solubilized phenyl-pyrazole ureas as potent, selective 5-HT(2A) inverse-agonists and their application as antiplatelet agents.

460. Rejuvenation of periosteal chondrogenesis using local growth factor injection.

461. Cell-permeating alpha-ketoglutarate derivatives alleviate pseudohypoxia in succinate dehydrogenase-deficient cells.

462. Lead optimization of 4-(dimethylamino)quinazolines, potent and selective antagonists for the melanin-concentrating hormone receptor 1.

463. Addressing religion and spirituality in psychotherapy: clients' perspectives 1.

464. Discovery of 4-(dimethylamino)quinazolines as potent and selective antagonists for the melanin-concentrating hormone receptor 1.

465. Measuring contextual characteristics for community health.

466. Prevalence of lower extremity arterial disease defined by the ankle-brachial index among American Indians: the Inter-Tribal Heart Project.

467. Geographic disparities in heart disease and stroke mortality among black and white populations in the Appalachian region.

468. Gene expression in colorectal cancer.

469. Women and cardiovascular disease: addressing disparities through prevention research and a national comprehensive state-based program.

471. Structure-activity relationships of novel 2-substituted quinazoline antibacterial agents.

472. Evidence of increasing coronary heart disease mortality among black men of lower social class.

473. Physical activity patterns of Chippewa and Menominee Indians: the Inter-Tribal Heart Project.

474. Heart failure survival among older adults in the United States: a poor prognosis for an emerging epidemic in the Medicare population.

475. Prevalence of multiple cardiovascular disease risk factors among women in the United States, 1992 and 1995: the Behavioral Risk Factor Surveillance System.

476. American Indian heritage and risk factors for renal injury.

477. Ischemic heart disease and stroke mortality in African-American, Hispanic, and non-Hispanic white men and women, 1985 to 1991.

478. The correspondence between coronary heart disease mortality and risk factor prevalence among states in the United States, 1991-1992.

479. Making the Pap smear into the "right tool" for the job.

480. Impact of multiple risk factor profiles on determining cardiovascular disease risk.

481. Ca2+ channel blockade by verapamil inhibits GMCs and diarrhea during small intestinal inflammation.

482. Pharmacologic management of heart failure among older adults by office-based physicians in the United States.

483. National trends in the initial hospitalization for heart failure.

484. Secular trends in ischemic heart disease mortality in California versus the United States, 1980 to 1991.

485. Leisure-time physical activity among older adults. United States, 1990.

486. Blood pressure, diabetes, and body mass index among Chippewa and Menominee Indians: the Inter-Tribal Heart Project Preliminary Data.

487. Race and sex differences in rates of invasive cardiac procedures in US hospitals. Data from the National Hospital Discharge Survey.

488. Trends in nonfatal coronary heart disease in the United States, 1980 through 1989.

489. Ins and outs of intrafacility transfers.

490. Uniformly modified 2'-deoxy-2'-fluoro phosphorothioate oligonucleotides as nuclease-resistant antisense compounds with high affinity and specificity for RNA targets.

491. A non-traditional request-for-proposals.

492. Antihypertensive treatment and US trends in stroke mortality, 1962 to 1980.

493. Reaching out to hospitals and physicians.

494. Geographic and socioeconomic variation in the onset of decline of coronary heart disease mortality in white women.

495. Variation in the magnitude of black-white differences in stroke mortality by community occupational structure.

496. Deciding to participate.

497. Saturation mutagenesis of a DNA region of bend. Base steps other than ApA influence the bend.

498. Passive smoking and 20-year cardiovascular disease mortality among nonsmoking wives, Evans County, Georgia.

499. Guanine tracts enhance sequence directed DNA bends.

500. Trends in the geographic inequality of cardiovascular disease mortality in the United States, 1962-1982.

Catalog

Books, media, physical & digital resources